0001225208-21-000868.txt : 20210115 0001225208-21-000868.hdr.sgml : 20210115 20210115215446 ACCESSION NUMBER: 0001225208-21-000868 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201214 FILED AS OF DATE: 20210115 DATE AS OF CHANGE: 20210115 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MUSSALLEM MICHAEL A CENTRAL INDEX KEY: 0001204551 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15525 FILM NUMBER: 21533666 MAIL ADDRESS: STREET 1: C/O EDWARDS LIFESCIENCES CORP STREET 2: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Edwards Lifesciences Corp CENTRAL INDEX KEY: 0001099800 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 364316614 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: 9492502500 MAIL ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP. DATE OF NAME CHANGE: 20090225 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP DATE OF NAME CHANGE: 20000203 FORMER COMPANY: FORMER CONFORMED NAME: CVG CONTROLLED INC DATE OF NAME CHANGE: 19991126 4 1 doc4.xml X0306 4 2020-12-14 0001099800 Edwards Lifesciences Corp EW 0001204551 MUSSALLEM MICHAEL A ONE EDWARDS WAY IRVINE CA 92614 1 1 Chairman & CEO Common Stock 2020-12-14 4 G 0 30000.0000 0.0000 D 279570.4600 D Common Stock 2021-01-15 4 M 0 98550.0000 13.9800 A 309770.4600 D Common Stock 2021-01-15 4 S 0 5308.0000 87.9300 D 304462.4600 D Common Stock 2021-01-15 4 G 0 30000.0000 0.0000 D 274462.4600 D Common Stock 2021-01-15 4 S 0 63242.0000 87.4600 D 211220.4600 D Common Stock 2021-01-15 4 G 0 30000.0000 0.0000 A 2913582.0000 I By Living Trust Common Stock 371736.8335 I 401(k) Employee Stock Option (Right to Acquire) 13.9800 2021-01-15 4 M 0 98550.0000 0.0000 D 2014-06-08 2021-05-07 Common Stock 98550.0000 361200.0000 D This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 3, 2020, but was omitted from the last Form 4 filed by the Reporting Person on December 15, 2020. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 3, 2020. This transaction was executed in multiple trades at prices ranging from $87.8400 to $88.1200. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $86.8400 to $87.8350. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Reflects shares represented on the most recent statement of the Issuer's 401(k) Plan Administrator. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. Linda J. Park, Attorney-in-Fact 2021-01-15